Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer [Phase 3]
A Phase 3 trial comparing docetaxel, doxorubicin, and cyclophosphamide versus vinorelbine and capecitabine as preoperative treatment for loc…
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway [Phase 3]
Phase 3 clinical trial evaluating inetetamab with rapamycin and chemotherapy for HER2-positive metastatic breast cancer with abnormal PAM pa…
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Prevention and Treatment of Pyrrolitinib-associated Diarrhea [Phase 2, Phase 3]
Phase 2/3 trial update evaluating prevention and treatment of diarrhea associated with pyrrolitinib in breast cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Eribulin in Combination With Cyclophosphamide in Patients With Solid Tumor Malignancies [Phase 1, Phase 2]
Phase 1/2 trial of eribulin with cyclophosphamide in malignant solid tumors and metastatic/recurrent breast cancer; study completed with res…
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Protective Role of Vitamin D in Breast Cancer Patients Treated With Doxorubicin [Phase 2]
Phase 2 trial examining whether vitamin D provides a protective effect in breast cancer patients treated with doxorubicin.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Denosumab as an add-on Neoadjuvant Treatment (GeparX) [Phase 2]
Phase 2 trial update on denosumab added to neoadjuvant therapy for various breast cancer subtypes; study completed.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Study of Nab-Paclitaxel in High Risk Early Breast Cancer [Phase 3]
Phase 3 trial update for nab-paclitaxel in high-risk early breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Cardiac Safety Study in Patients With HER2 + Breast Cancer [Phase 2]
A Phase 2 cardiac safety trial in HER2-positive breast cancer evaluated left ventricular function outcomes.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer [Phase 2]
Phase 2 trial evaluating anastrozole or fulvestrant in postmenopausal patients with breast cancer has completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: Analgesic Efficacy of Ultrasound Guided Erector Spinae Block for Modified Radical Mastectomy [Phase 2, Phase 3]
A clinical trial update evaluating the analgesic efficacy of ultrasound-guided erector spinae block for pain management after modified radic…
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: Phase III to Evaluate Patient´s Preference of Subcutaneous Trastuzumab vs Intravenous in HER2+ Advanced Breast Cancer [Phase 3]
Phase III trial updating patient preference for subcutaneous versus intravenous trastuzumab in HER2-positive advanced breast cancer has comp…
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: A Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease [Phase 3]
A Phase 3 trial evaluating metronomic oral vinorelbine in combination with aromatase inhibitors for postmenopausal women with HR-positive, H…
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: SV-BR-1-GM in Metastatic or Locally Recurrent Breast Cancer [Phase 1, Phase 2]
A phase 1/2 trial evaluating SV-BR-1-GM in metastatic or locally recurrent breast cancer has completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-28Clinical Trial Update: S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer [Phase 3]
Phase 3 trial investigating everolimus, anastrozole, and fulvestrant in post-menopausal stage IV breast cancer was terminated with posted re…
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer(CABC006) [Phase 2]
Multicenter Phase II study of apatinib in advanced breast cancer has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations [Phase 1, Phase 2]
Pilot trial of BMN 673 (olaparib) in advanced solid tumors with deleterious BRCA mutations completed phases 1 and 2; results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers [Phase 2]
Phase 2 pilot study evaluating durvalumab with Vigil in advanced women's cancers has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM) [Phase 1]
Phase 1 trial evaluating safety and tolerability of an MVA-based vaccine expressing brachyury and T-cell costimulatory molecules (MVA-Brachy…
-
CLINICAL_TRIALS trial_result · 2021-01-25Clinical Trial Update: Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations [NA]
A terminated clinical trial evaluating recombinant human chorionic gonadotropin for preventing breast cancer in premenopausal women with BRC…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer [Phase 1, Phase 2]
Clinical trial update for DOXIL (doxorubicin HCl liposome) in combination with Abraxane in metastatic breast cancer across Phase 1 and Phase…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD [Phase 2, Phase 3]
A phased clinical trial update for intensified autologous stem cell transplantation with peripheral blood progenitor cell support in breast …
-
CLINICAL_TRIALS trial_result · 2021-01-19Clinical Trial Update: Prospective Trial of Two Prone Breast Radiotherapy Techniques With Randomization to Concurrent Versus Weekly Boost [Phase 3]
Phase 3 trial comparing two prone breast radiotherapy techniques with randomization to concurrent versus weekly boost has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- High Risk Early Breast Cancer [Phase 2]
Phase 2 trial updating adjuvant ribociclib with endocrine therapy in high-risk HR+/HER2- early breast cancer has completed with results post…
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: The Digital Breast Tomosynthesis Trial in Bergen [NA]
The Digital Breast Tomosynthesis Trial in Bergen (NCT02835625) has completed, with results posted on January 15, 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Magnetic Seed Localisation of Breast Cancers [NA]
A completed clinical trial investigating magnetic seed localization for breast cancer; results posted in 2021.